X-67545316-TGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA-TGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_000044.6(AR):​c.219_239delGCAGCAGCAGCAGCAGCAGCA​(p.Gln74_Gln80del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00215 in 1,002,829 control chromosomes in the GnomAD database, including 11 homozygotes. There are 336 hemizygotes in GnomAD. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 8 hom., 100 hem., cov: 0)
Exomes 𝑓: 0.0015 ( 3 hom. 236 hem. )

Consequence

AR
NM_000044.6 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.40

Publications

10 publications found
Variant links:
Genes affected
AR (HGNC:644): (androgen receptor) The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]
AR Gene-Disease associations (from GenCC):
  • androgen insensitivity syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • Kennedy disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • partial androgen insensitivity syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • complete androgen insensitivity syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_000044.6
BP6
Variant X-67545316-TGCAGCAGCAGCAGCAGCAGCA-T is Benign according to our data. Variant chrX-67545316-TGCAGCAGCAGCAGCAGCAGCA-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 434262.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0113 (754/66602) while in subpopulation AFR AF = 0.0251 (472/18788). AF 95% confidence interval is 0.0233. There are 8 homozygotes in GnomAd4. There are 100 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARNM_000044.6 linkc.219_239delGCAGCAGCAGCAGCAGCAGCA p.Gln74_Gln80del disruptive_inframe_deletion Exon 1 of 8 ENST00000374690.9 NP_000035.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARENST00000374690.9 linkc.219_239delGCAGCAGCAGCAGCAGCAGCA p.Gln74_Gln80del disruptive_inframe_deletion Exon 1 of 8 1 NM_000044.6 ENSP00000363822.3 P10275-1

Frequencies

GnomAD3 genomes
AF:
0.0113
AC:
751
AN:
66615
Hom.:
8
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0250
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0109
Gnomad ASJ
AF:
0.00233
Gnomad EAS
AF:
0.0184
Gnomad SAS
AF:
0.0121
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.00654
Gnomad NFE
AF:
0.00475
Gnomad OTH
AF:
0.00748
GnomAD4 exome
AF:
0.00149
AC:
1398
AN:
936227
Hom.:
3
AF XY:
0.000802
AC XY:
236
AN XY:
294343
show subpopulations
African (AFR)
AF:
0.00888
AC:
210
AN:
23660
American (AMR)
AF:
0.00244
AC:
63
AN:
25803
Ashkenazi Jewish (ASJ)
AF:
0.000677
AC:
11
AN:
16246
East Asian (EAS)
AF:
0.00466
AC:
132
AN:
28324
South Asian (SAS)
AF:
0.00253
AC:
114
AN:
45067
European-Finnish (FIN)
AF:
0.00119
AC:
43
AN:
36138
Middle Eastern (MID)
AF:
0.00386
AC:
10
AN:
2589
European-Non Finnish (NFE)
AF:
0.00101
AC:
726
AN:
718563
Other (OTH)
AF:
0.00223
AC:
89
AN:
39837
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
62
124
187
249
311
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0113
AC:
754
AN:
66602
Hom.:
8
Cov.:
0
AF XY:
0.0121
AC XY:
100
AN XY:
8250
show subpopulations
African (AFR)
AF:
0.0251
AC:
472
AN:
18788
American (AMR)
AF:
0.0109
AC:
57
AN:
5236
Ashkenazi Jewish (ASJ)
AF:
0.00233
AC:
4
AN:
1714
East Asian (EAS)
AF:
0.0185
AC:
34
AN:
1839
South Asian (SAS)
AF:
0.0122
AC:
11
AN:
901
European-Finnish (FIN)
AF:
0.00198
AC:
4
AN:
2025
Middle Eastern (MID)
AF:
0.00752
AC:
1
AN:
133
European-Non Finnish (NFE)
AF:
0.00475
AC:
165
AN:
34708
Other (OTH)
AF:
0.00739
AC:
6
AN:
812
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.537
Heterozygous variant carriers
0
29
59
88
118
147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AR: BS1, BS2 -

Jun 24, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Apr 22, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Androgen resistance syndrome;C1839259:Kennedy disease Benign:1
Nov 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.4
Mutation Taster
=187/13
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3032358; hg19: chrX-66765158; API